VaxLiant® is a member of the AgriLabs® family of animal health companies supporting concept-to-commercialization of innovative products and services to customers in the U.S. and around the globe. Originally, it was an innovative joint venture formed between AgriLabs and Benchmark Biolabs. We provides innovative antigen-delivery systems and technical support that gives our customers the flexibility they need to develop and commercialize safe, effective vaccines
Headquartered in Lincoln, Nebraska, we offer a portfolio of ready-to-use ENABL® adjuvants and fully customizable BioMize adjuvants to modernize how vaccines deliver antigens to prevent disease. Our products help companies bring vaccines to market on time and on budget as they are flexible enough to create a specific immune response, minimize cell destruction, provide extended stability, and include no animal-origin materials that could compromise safety or create export/import restrictions of animals and animal products.
Our adjuvants are being used in three autogenous cattle vaccines, and are being used in over 50 research projects that are testing or developing new food animal vaccines.
Our team of experts has a track record of:
Tap into the expertise of the VaxLiant scientists and other specialists who collectively represent more than 100 years of experience in developing and marketing vaccines.
Timothy Miller, Ph.D.
Mary Ann Pfannenstiel, Ph.D.
Vice president, laboratory and quality control
Vice president, regulatory and quality assurance
Vice president, manufacturing
Director, marketing and business development
Executive Vice President
Vice President of Operations
Vice president, research and development
Chief financial officer
William Swafford, D.V.M.